Literature DB >> 28371600

HuR Stabilizes lnc-Sox5 mRNA to Promote Tongue Carcinogenesis.

Lifang Wang1, Shucheng Ye, Junye Wang, Zhenfang Gu, Yanhui Zhang, Chunmei Zhang, Xuezhen Ma.   

Abstract

Long noncoding RNAs (lncRNAs) have been recently regarded as systemic regulators in multiple biological processes including tumorigenesis. In this study, we report an ultra-highly expressed lncRNA, lnc-Sox5, in tongue tumor tissues. The results imply that lnc-Sox5 may play vital role in tongue carcinoma progression. We observed that the growth of Tca8113 cells was suppressed by lnc-Sox5 downregulation. Additionally, lnc-Sox5 knockdown simultaneously increased Tca8113 cell apoptosis, but the cell cycle was arrested. RNA immunoprecipitation suggested that HuR directly bound to and stabilized lnc-Sox5 RNA. Consistently, HuR knockdown reduced the level of lnc-Sox5 in Tca8113 cells. However, overexpression of HuR induced more lnc-Sox5 in Tca8113 cells. Both lnc-Sox5 knockdown and HuR knockdown suppressed Tca8113 cell tumorigenesis in xenograft models. These results suggest that lnc-Sox5, which was stabilized by HuR, could regulate carcinogenesis of tongue cancer and may serve as a predicted target for tongue carcinoma therapies.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28371600     DOI: 10.1134/S0006297917040046

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  9 in total

Review 1.  Long non-coding RNA implicated in the invasion and metastasis of head and neck cancer: possible function and mechanisms.

Authors:  Xiaobo Luo; Yan Qiu; Yuchen Jiang; Fangman Chen; Lu Jiang; Yu Zhou; Hongxia Dan; Xin Zeng; Yu L Lei; Qianming Chen
Journal:  Mol Cancer       Date:  2018-01-24       Impact factor: 27.401

2.  RBFOX1 Regulates the Permeability of the Blood-Tumor Barrier via the LINC00673/MAFF Pathway.

Authors:  Shuyuan Shen; Chunqing Yang; Xiaobai Liu; Jian Zheng; Yunhui Liu; Libo Liu; Jun Ma; Teng Ma; Ping An; Yang Lin; Heng Cai; Di Wang; Zhen Li; Lini Zhao; Yixue Xue
Journal:  Mol Ther Oncolytics       Date:  2020-03-30       Impact factor: 7.200

Review 3.  The Role of Long Non-coding RNAs in Immunotherapy Resistance.

Authors:  Yuwen Zhou; Yajuan Zhu; Yao Xie; Xuelei Ma
Journal:  Front Oncol       Date:  2019-11-28       Impact factor: 6.244

4.  Knockdown of lncRNA TDRG1 Inhibits Tumorigenesis in Endometrial Carcinoma Through the PI3K/AKT/mTOR Pathway.

Authors:  Ruimei Sun; Xiujiang Sun; Hua Liu; Peirui Li
Journal:  Onco Targets Ther       Date:  2019-12-11       Impact factor: 4.147

Review 5.  Long Non-Coding RNA (lncRNA) in Oral Squamous Cell Carcinoma: Biological Function and Clinical Application.

Authors:  Jianfei Tang; Xiaodan Fang; Juan Chen; Haixia Zhang; Zhangui Tang
Journal:  Cancers (Basel)       Date:  2021-11-26       Impact factor: 6.639

6.  Long Noncoding RNA ENSG00000254693 Promotes Diabetic Kidney Disease via Interacting with HuR.

Authors:  Qun Yu; Jiangong Lin; Qiqi Ma; Yanmei Li; Qianhui Wang; Huimin Chen; Yue Liu; Bing Liu
Journal:  J Diabetes Res       Date:  2022-04-19       Impact factor: 4.061

7.  Transcription Factor NFAT5 Promotes Glioblastoma Cell-driven Angiogenesis via SBF2-AS1/miR-338-3p-Mediated EGFL7 Expression Change.

Authors:  Hai Yu; Jian Zheng; Xiaobai Liu; Yixue Xue; Shuyuan Shen; Lini Zhao; Zhen Li; Yunhui Liu
Journal:  Front Mol Neurosci       Date:  2017-09-21       Impact factor: 5.639

Review 8.  Exosomes in head and neck cancer. Updating and revisiting.

Authors:  Samuel Rodríguez Zorrilla; Abel García García; Andrés Blanco Carrión; Pilar Gándara Vila; Manuel Somoza Martín; Mercedes Gallas Torreira; Mario Pérez Sayans
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

Review 9.  An immunotherapeutic approach to decipher the role of long non-coding RNAs in cancer progression, resistance and epigenetic regulation of immune cells.

Authors:  Krishnapriya M Varier; Hemavathi Dhandapani; Wuling Liu; Jialei Song; Chunlin Wang; Anling Hu; Yaacov Ben-David; Xiangchun Shen; Yanmei Li; Babu Gajendran
Journal:  J Exp Clin Cancer Res       Date:  2021-07-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.